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Abstract
This study examined the phenotypic profiles of children aged 30–68 months in the Study to 
Explore Early Development (SEED). Children classified as autism spectrum disorder (ASD), 
developmental delay (DD) with ASD symptoms, DD without ASD symptoms, and population 
comparison (POP) differed significantly from each other on cognitive, adaptive, behavioral, and 
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social functioning and the presence of parent-reported conditions. Children with ASD and DD 
with ASD symptoms had mild to severe ASD risk on several measures compared to children with 
other DD and POP who had little ASD risk across measures. We conclude that children in SEED 
have varying degrees of ASD impairment and associated deficits. SEED thus provides a valuable 
sample to explore ASD phenotypes and inform risk factor analyses.
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Introduction
Autism spectrum disorder (ASD) is a developmental disorder defined by impairments in 
social interaction and communication and the presence of restricted interests and repetitive 
behaviors (RRB) (American Psychiatric Association 2013). The Centers for Disease Control 
and Prevention (CDC) currently estimates that an average of 1 in 68 children from multiple 
US communities has an ASD, a substantial increase from previous reports (CDC 2014). It is 
widely accepted that both genetic and non-genetic factors are associated with the 
development of ASD (Bailey et al. 1995; Hallmayer et al. 2011; Miles 2011), although 
distinct genetic mechanisms have been found for only 10–25 % of all children with an ASD 
(Abrahams and Geschwind 2008; Geschwind 2011; Miles 2011) and neither genetic nor 
non-genetic mechanisms are well understood. The search for ASD risk factors that could 
lead to preventive measures or treatment options has thus become a national research 
priority (Interagency Autism Coordinating Committee 2014).
One of the difficulties in ASD etiologic research arises from the substantial variability in 
ASD symptom severity and presentation, and in co-occurring behavioral, psychiatric, and 
medical conditions (Carlsson et al. 2013; Close et al. 2012; Levy et al. 2010). This 
phenotypic complexity is often apparent from the very early stages of development in 
children subsequently diagnosed with ASD. Most preschool children with ASD have more 
cognitive, adaptive, behavioral, and social delays than children with other developmental 
delays (DD) and typical development; although constellations of symptoms may vary among 
individual children. Severity gradients within the two diagnostic domains of social 
communication and RRB also range from mild to severe and do not always follow the same 
pattern across domains (e.g., some children may have severe social communication deficits 
and few RRB while other children may have mild social communication deficits and many 
RRB, Georgiades et al. 2013). Moreover, there is some indication that milder ASD 
symptoms extend beyond the classification of ASD, implicating a more dimensional than 
categorical developmental construct (Constantino 2011). Contrasting children with a range 
of ASD- and non ASD-related symptoms may thus provide insight into the causes of and 
treatments specific to ASD than considering only children with classic ASD symptomology.
The average age of earliest ASD diagnosis in the Unites States is 4.4 years (CDC 2014), 
which complicates research on the range of ASD phenotypes in early childhood. 
Consequently, screening children with an array of developmental conditions that often co-
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occur with or are diagnosed before ASD is an ideal way to detect those with varying levels 
of ASD impairments. For instance, many preschool children with ASD may also have 
symptoms of attention deficit hyperactivity disorder (ADHD), intellectual disability (ID), 
language delays, and motor delays; (Carlsson et al. 2013); epilepsy and sensory integration 
disorder are commonly reported in older children with ASD (Levy et al. 2010; Peacock et al. 
2012). Other children with ASD are not recognized with any DD until screened in a general 
pediatric setting (Miller et al. 2011). Few studies, however, have systematically screened for 
ASD in large samples of children, both with and without other DD, to ascertain ASD-related 
impairments and compare phenotypic profiles of children classified on the basis of a 
comprehensive developmental assessment. Although challenging to obtain, such an in-
depth, standardized assessment of a large sample of children in multiple geographic areas 
would provide a valuable sample to explore various ASD phenotypes and inform risk factor 
analyses.
The Study to Explore Early Development (SEED) is a multi-site case–control study 
designed to explore possible risk factors for the development of ASD (Schendel et al. 2012; 
Wiggins et al. 2015). SEED presents a distinct opportunity to investigate a range of ASD 
phenotypes because of its large sample size, comprehensive data collection, and multiple 
comparison groups [i.e., ASD, DD, including DD with ASD symptoms, and population 
comparison (POP)]. Consequently, the goal of this paper is to compare the global 
phenotypic profile of children with ASD to the global phenotypic profile of children 
classified as DD with and without ASD symptoms and POP in SEED. We hypothesized that 
children with ASD would have more cognitive, adaptive, behavioral, and social deficits than 
other children in SEED; followed in order by children classified as DD with ASD 
symptoms, DD without ASD symptoms, and POP. We also hypothesized that children 
classified as DD with ASD symptoms would have more parent-reported ADHD, language 
delays, and motor delays than children classified as DD without ASD symptoms and POP. 
We intend this descriptive study as a first step in elucidating ASD phenotypes in children 
identified through SEED, thus setting the stage for future and more detailed analyses on 
individual symptoms and the link between phenotypes and etiologies.
Methods
Participant Ascertainment
SEED is a case–control study conducted in six study sites across the United States: 
California, Colorado, Georgia, Maryland, North Carolina, and Pennsylvania, and approved 
by Institutional Review Boards (IRB) at each site. Eligible children were born between 
September 1, 2003 and August 31, 2006 (30–68 months of age), resided in one of the six 
study catchment areas at birth and the time of first contact by SEED study staff, and lived 
with a knowledgeable caregiver who was competent to communicate orally in English (or in 
California and Colorado, in English or Spanish). A three-pronged strategy was designed to 
ascertain the SEED sample: (1) children in the POP group were identified from a random 
sample of birth certificates from state vital records, (2) children with potential ASD and DD 
were identified in each study area from multiple educational and health providers who 
diagnose and serve children with a range of developmental disabilities including ASD, and 
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(3) children with a potential ASD diagnosis were also referred by families or physicians. A 
detailed description of the SEED eligibility criteria, ascertainment methods, enrollment 
methods, and data collection protocol can be found in Schendel et al. (2012). Data from this 
analysis were collected in the original SEED protocol and did not require additional data 
collection or IRB approval.
ASD Screening and Study Data Collection Procedures
The Social Communication Questionnaire (SCQ; Rutter et al. 2003) was administered to 
screen for ASD. The SCQ score provided an initial quantification of the child’s risk of ASD 
and identified whether the child would be tested for ASD, enabling more efficient use of 
study resources. The SCQ recommends a score of 15 points or greater as an indicator of risk 
for an ASD. However, based on past research that indicates an SCQ score of 11 maximizes 
sensitivity and specificity in young children, SEED investigators defined an SCQ score of 
11 points or higher as an indicator of risk for an ASD (Allen et al. 2007; Lee et al. 2007; 
Wiggins et al. 2007). Analyses that support a SCQ cutoff score of 11 points in young 
children were subsequently replicated in the SEED sample (unpublished data).
Children with an SCQ score less than 11 points and without a previous ASD diagnosis were 
asked to complete a clinic visit consisting of administration of the Mullen Scales of Early 
Learning (MSEL) (Mullen 1995). If children scored a standard score of less than 78 standard 
points on the MSEL, the Vineland Adaptive Behavior Scales— Second Edition (VABS-II) 
(Sparrow et al. 2005) was also administered to the parent. Children and parents of children 
who obtained a score of 11 or higher on the SCQ or had a previous ASD diagnosis were 
asked to complete a more comprehensive developmental evaluation that consisted of the 
Autism Diagnostic Interview-Revised (ADI-R), Autism Diagnostic Observation Schedule 
(ADOS), MSEL, and VABS-II. These assessments were administered during one to three 
clinic visits by clinicians who had established research reliability. A small number of 
children who scored less than 11 points on the SCQ and did not have a previously 
documented ASD diagnosis were also administered the comprehensive evaluation if the 
study clinician suspected ASD during the clinic visit.
Additional information on phenotypic characteristics and ASD symptoms and behaviors was 
obtained via parent report on the Child Behavior Checklist (CBCL; Achenbach 1992), 
Social Responsiveness Scale (SRS; Constantino 2002), and a structured interview that 
collected information on demographics and a range of developmental, medical, and 
psychiatric conditions. Parents were provided with a preparation guide before the interview 
so they could collect information to reduce recall bias. The specific question used to assess 
developmental, medical, and psychiatric conditions was “Now I will ask you about some 
developmental information a doctor or health care provider may have told you about your 
child. Please note that a health care provider at the child’s school such as a child 
psychologist, physical therapist, occupational therapist, or school nurse should also be 
considered a qualified health care professional in answering these questions; however, the 
child’s teachers should not be considered health care providers. Has a doctor or health care 
provider ever told you that your child had or has any of the conditions in the preparation 
guide?” The interviewer would then read a list of conditions to the parent but did not 
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provide a definition of each condition for the parent. Therefore, these conditions represent 
parent-reported conditions that were presumably diagnosed any time before the interview 
but were not used to ascertain children for the study. Likewise, symptoms of these 
conditions may overlap with or reflect ASD symptoms in the child. See Table 1 and Table 2 
for a list of study instruments used for this paper. All instruments collected in SEED are 
described in detail elsewhere (Schendel et al. 2012).
Final Study Classification
The SEED final classification algorithm was based on best practice guidelines, review of the 
literature, clinical experience, and a desire to create a uniform method of characterizing 
ASD symptoms in large cohorts of children. Final classifications were based on the results 
of the ADI-R and ADOS, with careful consideration of the child’s overall developmental 
level. The SEED classification algorithm therefore considered ASD symptoms relevant to 
both the 4th and 5th editions of the diagnostic and statistical manual of mental disorders 
(American Psychiatric Association 1994,2013). Briefly, children classified as ASD were 
those who met ASD criteria on both the ADOS and ADI-R or who met ASD criteria on the 
ADOS and one of three alternate criteria on the ADI-R (i.e., met criteria on the social 
domain and was within two points on the communication domain, met criteria on the 
communication domain and was within two points on the social domain, or met criteria on 
the social domain and had two points noted on the behavioral domain). Details on the SEED 
final classification algorithm can be found in Wiggins et al. (2015).
Children who did not meet SEED ASD criteria were initially classified into one of three 
additional final classification groups: (1) DD, (2) POP, and (3) Incomplete Classification. 
Children classified as DD were those identified in each study area from multiple educational 
and health providers who diagnose and serve children with a range of developmental 
disabilities including ASD. These children did not demonstrate ASD risk on the SCQ and/or 
did not meet the SEED ASD criteria. Children classified as DD were ascertained on the 
basis of having various developmental conditions possibly related to ASD, such as ADHD 
and language delay, among other diagnoses. These children were divided post hoc into two 
subgroups based on different ASD-specific symptom profiles. Children classified as DD 
with ASD symptoms were those who received a comprehensive developmental evaluation 
for ASD but did not meet the threshold for SEED ASD criteria. Children classified as DD 
without ASD symptoms were those who received a limited developmental evaluation 
because they did not have a previous ASD diagnosis noted in service records and scored 
below 11 points on the SCQ. Children classified as POP were those who were ascertained 
from birth records and received a limited developmental evaluation or received a 
comprehensive developmental evaluation but did not meet the SEED criteria for a final 
classification of ASD. Children classified as Incomplete Classification were those who were 
asked to complete a comprehensive developmental evaluation but did not complete the 
evaluation for any reason, and were thus excluded from these analyses.
Statistical Methods
Descriptive statistics were used to summarize the distribution of children in each SEED 
study group by child age, ethnicity, race, and sex. Omnibus Chi square analyses tested for 
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differences in child age, ethnicity, race, and sex and parent-reported conditions across all 
study groups; p values for these analyses show statistical differences for the omnibus test 
instead of statistical differences between individual study groups. Pairwise Chi square 
comparisons were conducted to show statistical differences between SEED study groups; 
pairwise Chi square analyses were corrected for multiple comparisons with the Bonferroni 
method. The Phi statistic (φ) is reported for these analyses to indicate the measure of 
association between binary variables.
Where sample size prevented stratification by child’s race, sex, and study site, we report 
aggregate results on developmentally appropriate conditions noted in at least 1 % of our 
sample.
ANCOVA analyses were conducted to assess mean differences in cognitive, adaptive, 
behavioral, and social functioning and ASD symptom severity between study groups while 
controlling for the influence of child race, child sex, and study site. A Bonferonni correction 
was applied to ANCOVA analyses to account for multiple comparisons. Partial eta squared 
(η2p) is reported for these analyses to indicate the amount of variance in cognitive, adaptive, 
behavioral, and social functioning and ASD symptom severity accounted for by SEED final 
classification.
Results
A total of 3,769 index children were enrolled in SEED, 2,722 (72.2 %) attended a clinic 
visit, and 2,600 (68.9 %) completed enough of the clinic visit to be classified as ASD or 
non-ASD. The 122 children who attended a clinic visit but were not classified as ASD or 
non-ASD were excluded from the analyses due to incomplete or invalid data collection. The 
sample described in this paper is those 2,600 children who were classified as ASD or non-
ASD (Fig. 1). Demographic information by ASD, DD, and POP study groups is presented in 
Table 3.
The SEED final classifications for the 2,600 children in these analyses were: ASD (n = 707), 
DD (n = 995), and POP (n = 898). Children with ASD were ascertained from community 
based service providers due to an ASD or other DD diagnosis (n = 697). Some children 
identified from birth certificate records also met study criteria for ASD (n = 10). Children 
classified as DD were ascertained from community based service providers due to an ASD 
or DD diagnosis (n = 995); children with a previous ASD diagnosis were retained in the DD 
group if they did not meet our study criteria for ASD. Children classified as POP were 
ascertained from birth certificate records (n = 898). As mentioned previously, the DD study 
group was divided into children with ASD symptoms (n = 305) and children without ASD 
symptoms (n = 690). There were no significant differences in any MSEL, CBCL, or SRS 
domain between DD children with ASD symptoms who did and did not meet criteria on at 
least one of the ADI-R or ADOS. In contrast, there were significant differences in almost all 
MSEL, CBCL, and SRS domains between DD children who (1) had ASD symptoms and did 
not meet at least one of the ADI-R or ADOS classification thresholds and (2) did not have 
ASD symptoms (the only exception being the MSEL fine motor domain). The definition of 
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children classified as DD with ASD symptoms thus remained children who received a 
comprehensive evaluation for ASD but did not meet SEED ASD criteria.
There were 1487 caregivers (53.4 %) who reported that a health care professional told them 
that their child had at least one behavioral, developmental, medical, and psychiatric 
condition other than ASD. There were differences in the frequencies of parent-reported 
conditions based on child race, child sex, and study site. However, we were unable to 
stratify our analyses on these variables due to the low frequencies of some conditions among 
study groups.
The most common conditions reported by parents of children with ASD were language 
delay (65.6 %), sensory integration disorder (27.9 %), and motor delay (19.5 %). Children 
with ASD had more parent-reported sensory integration disorder and vision problems than 
children in other study groups. Children classified as DD with ASD symptoms had more 
parent-reported ADHD than children in other study groups, and children classified as DD 
without ASD symptoms had more parent-reported Down syndrome than children in other 
study groups (Table 4). Children classified as ASD and those classified as DD with ASD 
symptoms had similar frequencies of parent-reported language delays, obsessive compulsive 
disorder (OCD), and self-injurious behaviors, and the prevalence of OCD and self-injurious 
behaviors in each of these two groups was higher than those reported among children 
classified as DD without ASD symptoms and POP (Table 4). Children in the POP group had 
the lowest prevalence of all parent-reported conditions.
Conditions not noted in at least 1 % of the sample and thus dropped from further analyses, 
included childhood schizophrenia (n = 0), Rett syndrome (n = 0), tuberous sclerosis (n = 1), 
childhood disintegrative disorder (n = 2), Tourette syndrome (n = 2), neurofibromatosis (n = 
5), reactive attachment disorder (n = 6), bipolar disorder (n = 7), and Fragile × syndrome (n 
= 7).
Of the 2,600 children in these analyses, 99.1 % had MSEL early learning composite scores 
available, 99.4 % had SCQ scores available, 92.8 % had CBCL scores available, and 90.6 % 
had SRS scores available. Table 5 shows mean differences in cognitive, behavioral, and 
social functioning based on these measures while controlling for the influence of child race, 
child sex, and study site. There was a clear and progressive pattern demonstrating significant 
group differences in cognitive, behavioral, and social functioning even after controlling for 
covariates. Children with ASD showed the most deficits across measures, followed in order 
by children classified as DD with ASD symptoms, DD without ASD symptoms, and POP. 
There were significant differences in the mean performance of children classified as DD 
with ASD symptoms and DD without ASD symptoms across all MSEL, SCQ, SRS, and 
CBCL composite and domain scores.
Children classified as ASD or DD with ASD symptoms (n = 1012) completed an ADI-R and 
ADOS, and 99.3 % of these children completed at least one domain of the VABS-II. Table 6 
shows differences in mean adaptive functioning and autism symptom scores between 
children with ASD and children with DD with ASD symptoms as a function of final 
classification. Children classified as ASD had more adaptive deficits than children classified 
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as DD with ASD symptoms. Children with ASD had more ASD-related symptoms as 
measured by the ADI-R than children classified as DD with ASD symptoms. Children with 
ASD also had a higher mean ADOS symptom severity score than children classified as DD 
with ASD symptoms (range 4–10 and M = 7, which translates as moderate symptom 
severity versus range 1–10 and M = 3, which translates as low symptoms severity, 
respectively).
Discussion
Our results confirm that children within the SEED sample have varying degrees of ASD 
symptoms and associated deficits. Children were delineated into four research groups based 
on ascertainment and clinical assessment: children with ASD had more cognitive, adaptive, 
behavioral, and social delays than other children in SEED, followed in order by children 
classified as DD with ASD symptoms, DD without ASD symptoms, and POP. Children 
classified as DD with ASD symptoms were significantly more impaired than children with 
other DD across all cognitive, behavioral, and social domains. Moreover, children classified 
as DD with ASD symptoms had mild ASD symptoms noted on both the ADOS and SRS 
compared to children with ASD who had moderate ASD symptoms noted on the ADOS and 
SRS (and children with other DD and POP who scored within the typical range on the SRS). 
These results support the idea that children classified as DD with ASD symptoms may 
represent a phenotype characterized by subthreshold ASD traits. These results also highlight 
the many needs of children with ASD symptoms and associated deficits and support future 
research to identify individual symptoms and risk factors that contribute to ASD symptom 
severity.
Many of the conditions reported on the caregiver interview comprise symptoms that overlap 
with ASD symptoms (e.g., ADHD, language delay, and sensory integration disorder) and 
may therefore represent different aspects of ASD phenotypes rather than distinct and co-
occurring conditions. Nonetheless, it is important to highlight conditions that are reported 
frequently in children classified as ASD and DD with ASD symptoms so that future research 
can more thoughtfully examine individual symptoms that contribute to ASD phenotypes and 
their associated risks. Caregivers noted sensory integration disorder in 27.9 % of children 
with ASD, and this was the second most common condition reported in children with ASD 
and DD with ASD symptoms (after language delays). Previous research among similarly 
aged children suggests that more than 80 % of children with ASD have definite sensory 
integration problems when outcomes are based on the results of symptom questionnaires 
rather than probing about previously reported conditions (Tomchek and Dunn 2007). Future 
research should thus explore the role of sensory systems in the development and 
manifestation of ASD and interventions to address sensory concerns.
Children classified as DD with ASD symptoms were more similar to children with ASD 
than children with DD alone in terms of some parent-reported conditions. For instance, 
children classified as DD with ASD symptoms had similar frequencies of parent-reported 
language delays, OCD, and self-injurious behaviors as children with ASD, and the 
occurrences of parent-reported OCD and self-injurious behaviors were higher than those 
found in other study groups. Symptoms of OCD and self-injurious behaviors are common 
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among children with ASD and may be perceived by providers to be part of the ASD 
phenotype. Consequently, children classified as DD with ASD symptoms in SEED could 
represent an ASD trajectory defined by significant improvement (if previously diagnosed 
with ASD) or symptoms not fully expressed (if not previously diagnosed with ASD). 
Children with DD and ASD symptoms thus offer a unique opportunity to expand our 
understanding of diverse ASD profiles (Gerdts and Bernier 2011). Future studies using a 
general DD comparison group should consider the presence/absence of ASD features when 
defining children with DD in order to produce more phenotypic specificity. Future studies 
should also consider longitudinal analyses of children with various levels of ASD symptoms 
to elucidate different pathways of development.
Children classified as DD with ASD symptoms had more parent-reported ADHD (but not 
more parent-reported language or motor delays) than any other study group. Previous 
research shows that symptoms of ADHD occur in about 50 % of individuals with ASD, 
suggesting high phenotypic overlap and potential difficulty with differential diagnosis 
between these two conditions (Goldstein and Schwebach 2004; Sinzig et al. 2009). Etiologic 
risks implicated in both ADHD and ASD include genetic factors, maternal infection during 
pregnancy, maternal auto-immune disease, maternal psychotropic medication use, and pre-
term birth (Taurines et al. 2012). Future research could examine overlapping symptoms 
between ADHD and ASD that contribute to symptom endorsement in both conditions or 
suggest common etiologic risks (Taurines et al. 2012; van der Meer et al. 2012). More 
comparative research is needed on specific phenotypic distinctions between ADHD and 
ASD and their influences on early development to guide etiologic research.
The POP comparison group was developmentally similar to what we would expect of 
children in the general population. Children classified as POP had a mean MSEL standard 
score of 102 and mean MSEL domain scores between 49 and 52, which represents average 
cognitive performance in this group (Table 1). Children classified as POP also showed few 
internalizing and externalizing behavior problems on the CBCL and few ASD symptoms on 
the SCQ and SRS. For most of the conditions reported in the caregiver interview, the 
prevalence among children in the POP group was comparable to estimates from other 
studies (Boyle et al. 2011; Law et al. 2000), supporting the conclusion that the POP group is 
phenotypically representative of the general population and thereby a valid general 
population comparison group for SEED etiologic analysis.
Parent-reported conditions among children in SEED were generally consistent with other 
reports of young children, although there were a few notable discrepancies. The rate of 
ADHD was lower among children classified as ASD (8.0 %), other DD (4.5 %), and POP 
(0.8 %) than expected given other analyses (Boyle et al. 2011; Levy et al. 2010; Simonoff et 
al. 2008; Visser et al. 2010). Additionally, the rate of epilepsy was lower among children 
classified as ASD (3.7 %) given other analyses (Tuchman et al. 2010; Viscidi et al. 2013). 
Both ADHD and epilepsy are more often diagnosed in older children than preschool 
children, so the young age of the SEED sample could explain the lower rates of ADHD and 
epilepsy reported in this paper. Finally, children classified as POP had a higher rate of 
undefined hearing problems (1.5 %) compared to other estimates (Boyle et al. 2011; Visser 
et al. 2010) derived from questions about moderate to profound hearing loss rather than a 
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hearing problem. Thus, the differences in reported hearing problems between SEED and 
other studies could be due to the framing of questions rather than unique characteristics of 
the SEED sample.
There are some limitations to our analysis that warrant discussion. First, parent-reported 
conditions were obtained via caregiver interview rather than by direct assessment of the 
child; site differences in the presence of parent-reported conditions could indicate state 
differences in the recognition or interpretation of developmental problems and the quality of 
services for those problems. There were also differences in parent-reported conditions based 
on child race and sex, although we were unable to stratify our analyses on these 
characteristics due to the low frequencies of some conditions among study groups. These 
analyses should therefore be interpreted with caution since results could vary depending on 
geographic region or race or sex of the child. Moreover, the racial and ethnic distribution of 
the sample was slightly different from other large-scale investigations in that the SEED 
sample comprised more White, Black, and multi-racial children and less Asian and Hispanic 
children. Sample demographics were expected to vary between SEED and other studies 
given different geographic locales and method of reporting child race and ethnicity versus 
maternal race and ethnicity (Walker et al. 2014).
Despite these limitations, our results suggest that SEED study groups represent children with 
varying degrees of ASD symptoms and associated deficits. Of particular importance was the 
identification of children with a range of ASD impairments that could help elucidate 
etiologic pathways of development. Children classified as ASD and DD with ASD 
symptoms are noteworthy in that they are more phenotypically similar to each other than 
children classified as other DD or POP (e.g., they have more cognitive, adaptive, behavioral, 
and social delays, and symptoms of OCD, self-injurious behaviors, and sensory integration 
problems than children classified as DD or POP). These data are important because they 
provide preliminary clues to pivotal symptoms that may help delineate ASD phenotypes and 
etiologies. Children with other DD and POP offer ideal comparison groups to explore ASD 
symptom specificity given few social communication concerns. We thus conclude that the 
SEED study groups offer an excellent opportunity to explore ASD phenotypes and inform 
future risk factor analyses.
Acknowledgments
We would like to thank Aimee Alexander for her assistance with data cleaning and the SEED principal 
investigators, co-principal investigators, project coordinators, project staff, and children and families who 
participated in this research. This publication was supported by six cooperative agreements from the Centers for 
Disease Control and Prevention: Cooperative Agreement Number U10DD000180, Colorado Department of Public 
Health; Cooperative Agreement Number U10DD000181, Kaiser Foundation Research Institute (CA); Cooperative 
Agreement Number U10DD000182, University of Pennsylvania; Cooperative Agreement Number U10DD000183, 
Johns Hopkins University; Cooperative Agreement Number U10DD000184, University of North Carolina at 
Chapel Hill; and Cooperative Agreement Number U10DD000498, Michigan State University. The findings and 
conclusions in this report are those of the authors and do not necessarily represent the official position of the 
Centers for Disease Control and Prevention.
References
Abrahams BS, Geschwind DH. Advances in autism genetics: On the threshold of a new neurobiology. 
Nature Review Genetics. 2008; 9(5):341–355.
Wiggins et al. Page 10













Achenbach, T. Child behavior checklist. Burlington, VT: Achenbach System of Empirically based 
Assessment; 1992. 
Allen C, Silove N, Williams K, Hutchins P. Validity of the social communication questionnaire in 
assessing risk of autism in preschool children with developmental problems. Journal of Autism and 
Developmental Disorders. 2007; 37(7):1272–1278. [PubMed: 17080270] 
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.. 
Arlington, VA: American Psychiatric Publishing; 1994. 
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed.. 
Arlington, VA: American Psychiatric Publishing; 2013. 
Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff P, Yuzda E, Rutter M. Autism as a strongly 
genetic disorder: Evidence from a British twin study. Psychological Medicine. 1995; 25(1):63–77. 
[PubMed: 7792363] 
Boyle CA, Boulet S, Schieve LA, Cohen RA, Blumberg SJ, Yeargin-Allsopp M, et al. Trends in the 
prevalence of developmental disabilities in US children, 1997–2008. Pediatrics. 2011; 127:1034–
1042. [PubMed: 21606152] 
Carlsson LH, Norrelgen F, Kjellmer L, Westerlund J, Gillberg C, Fernell E. Coexisting disorders and 
problems in preschool children with autism spectrum disorder. The Scientific World Journal. 2013; 
2013:1–6.
Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders among children 
8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. 
MMWR Surveillance Summaries. 2014; 63(SS02):1–21.
Close HA, Lee L-C, Kaufmann CN, Zimmerman AW. Co-occurring conditions and change in 
diagnosis in autism spectrum disorder. Pediatrics. 2012; 129:305–316.
Constantino, J. The social responsiveness scale. Los Angeles, CA: Western Psychological Services; 
2002. 
Constantino J. The quantitative nature of autistic social impairment. Pediatric Research. 2011; 
69:55R–62R.
Department of Health and Human Services Interagency Autism Coordinating Committee. website: 
http://iacc.hhs.gov/strategic-plan/2013/index.shtml
Georgiades S, Szatmari P, Boyle M, Hanna S, Duku E, Zwaigenbaum L, et al. Investigating 
phenotypic heterogeneity in children with autism spectrum disorder: A factor mixture modeling 
approach. Journal of Child Psychology and Psychiatry. 2013; 54:206–215. [PubMed: 22862778] 
Gerdts J, Bernier R. The broader autism phenotype and its implications on the etiology and treatment 
of autism spectrum disorders. Autism Research and Treatment. 2011; 2011:545901. Epub 2011 
Aug 17. [PubMed: 22937250] 
Geschwind DH. The genetics of autism spectrum disorders. Trends in Cognitive Science. 2011; 15(9):
409–416.
Goldstein S, Schwebach AJ. The comorbidity of pervasive developmental disorder and attention 
deficit hyperac-tivity disorder: Results of a retrospective chart review. Journal of Autism and 
Developmental Disorders. 2004; 34:329–339. [PubMed: 15264500] 
Gotham K, Risi S, Pickles A, Lord C. The autism diagnostic observation schedule: Revised algorithms 
for improved diagnostic validity. Journal of Autism and Developmental Disorders. 2007; 37:613–
627. [PubMed: 17180459] 
Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and 
shared environmental factors among twin pairs with autism. Archives of General Psychiatry. 2011; 
68:1095–1102. [PubMed: 21727249] 
Interagency Autism Coordinating Committee (IACC). IACC strategic plan for autism spectrum 
disorder (ASD) research— 2013 Update. 2014 April 2014. Retrieved from the US. 
Law J, Boyle J, Harris F, Harkness A, Nye C. Prevalence and natural history of primary speech and 
language delay: Findings from a systematic review of the literature. International Journal of 
Language and Communication Disorders. 2000; 35(2):165–188. [PubMed: 10912250] 
Lee L, David AB, Rusyniak J, Landa R, Newschaffer CJ. Performance of the social communication 
questionnaire in children receiving preschool special education services. Research in Autism 
Spectrum Disorders. 2007; 1:126–138.
Wiggins et al. Page 11













Levy SE, Giarelli E, Lee LC, Schieve L, Kirby R, Cunniff C, et al. Autism spectrum disorder and co-
occurring developmental, psychiatric, and medical conditions among children in multiple 
populations of the United States. Journal of Developmental and Behavioral Pediatrics. 2010; 
31(4):267–275. [PubMed: 20431403] 
Lord C, Risi S, Lambrecht L, Cook EH Jr, Leventhal BL, DiLavore PC, et al. the autism diagnostic 
observation schedule-generic: A standard measure of social and communication deficits associated 
with the spectrum of autism. Journal of Autism and Developmental Disorders. 2000; 30(3):205–
223. [PubMed: 11055457] 
Lord, C.; Rutter, M.; DiLavore, PC.; Risi, S. Autism diagnostic observation schedule. Los Angeles, 
CA: Western Psychological Services; 1999. 
Lord C, Rutter M, Le Couteur AL. Autism diagnostic interview-revised: A revised version of a 
diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. 
Journal of Autism and Developmental Disorders. 1994; 24(5):659–685. [PubMed: 7814313] 
Miles JH. Autism spectrum disorders: A genetics review. Genetic Medicine. 2011; 13:278–294.
Miller JS, Gabrielsen T, Villalobos M, Alleman R, Wahmhoff M, Carbone PS, Sequra P. The each 
child study: Systematic screenign for autism spectrum disorders in a pediatric setting. Pediatrics. 
2011; 127:866–871. [PubMed: 21482605] 
Mullen, E. Mullen scales of early learning. San Antonio, TX: Pearson; 1995. 
Peacock G, Djesika A, Lijing O, Grosse S. Autism spectrum disorders and health care expenditures: 
The role of co-occurring conditions. Journal of Developmental and Behavioral Pediatrics. 2012; 
33:2–8. [PubMed: 22157409] 
Rutter, MA.; Bailey, A.; Lord, C. The social communication questionnaire. Los Angeles, CA: Western 
Psycholgical Services; 2003. 
Schendel D, DiGuiseppi C, Croen L, Fallin D, Reed P, Schieve L, et al. The study to explore early 
development (SEED): A multi-site epidemiologic study of autism by the centers for autism and 
developmental disabilities research and epidemiology (CADDRE) network. Journal of Autism and 
Developmental Disorders. 2012; 42:2121–2140. [PubMed: 22350336] 
Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in children 
with autism spectrum disorders: Prevalence, comorbidity, and associated factors in a population-
derived sample. Journal of the American Academy of Child and Adolescent Psychiatry. 2008; 
47(921):929.
Sinzig J, Walter D, Doepfner M. Attention deficit/ hyperactivity disorder in children and adolescents 
with autism spectrum disorder: Symptom or syndrome? Journal of Attention Disorders. 2009; 
13(2):117–126. [PubMed: 19380514] 
Sparrow, S.; Balla, D.; Cicchetti, D. Vineland adaptive behavior scales. 2nd ed.. San Antonio, TX: 
Pearson; 2005. 
Taurines R, Schwenck C, Westerwald E, Sachse M, Siniatchkin M, Freitag C. ADHD and autism: 
differential diagnosis or obverlapping traits? A selective review. Attention Deficit Hyperactivity 
Disorders. 2012; 4:115–139. [PubMed: 22851255] 
Tomchek SD, Dunn W. Sensory processing in children with and without autism: A comparative study 
using the short sensory profile. American Journal of Occupational Therapy. 2007; 61:190–200. 
[PubMed: 17436841] 
Tuchman R, Cucarro M, Alessandri M. Autism and epilepsy: Historical perspective. Brain and 
Development. 2010; 32(9):709–718. [PubMed: 20510557] 
van der Meer JM, Oerlemans AM, van Steijn DJ, Lappenschaar MG, de Sonneville LM, Buitelaar JK, 
Rommelse NN. Are autism spectrum disorder and attention deficit hyperactivity disorder different 
manifestations of one overarching disorder? Cognitive and symptom evidence from a clinical and 
population-based sample. Journal of the American Academy of Child and Adolescent Psychiatry. 
2012; 51:1160–1172. [PubMed: 23101742] 
Viscidi EW, Triche EW, Pescosolido MF, McLean RL, Joseph RM, Spense SJ, Morrow EM. Clinical 
characteristics of children with autism spectrum disorder and co-occurring epilepsy. PLoS ONE. 
2013; 8(7):e67797. [PubMed: 23861807] 
Wiggins et al. Page 12













Visser SN, Bitsko RH, Danielson ML, Perou R. Increasing prevalence of parent-reported attention 
deficit hyper-activity disorder among children—United States, 2003 and 2007. MMWR 
Surveillance Summaries. 2010; 59:1439–1443.
Walker CK, Krakowiak P, Baker A, Hansen R, Ozonoff S, Hertz-Picciotto I. Preecalmpsia, placental 
insufficiency, and autism spectrum disorder or developmental delay. JAMA Pediatrics. 2014 
Advance on-line publication. 
Wiggins LD, Bakeman R, Adamson LB, Robins DL. The utility of the social communication 
questionnaire in screening for autism in children referred for early intervention. Focus on Autism 
and Other Developmental Disabilities. 2007; 22:33–38.
Wiggins LD, Reynolds A, Rice C, Moody EJ, Bernal P, Blaskey L, et al. Using standardized 
diagnostic instruments to classify children with autism in the study to explore early development. 
Journal of Autism and Developmental Disorders. 2015; 45:1271–1280. [PubMed: 25348175] 
Wiggins et al. Page 13














Participant selection criteria for the 2600 children described in these analyses
Wiggins et al. Page 14

























Wiggins et al. Page 15
Table 1
Instruments administered to all participants in the Study to Explore Early Development








Child developmental, medical, and 
psychiatric
conditions that the parent reported was
endorsed by a health care provider any 
time
prior to the interview
Presence of parent-reported 
condition
recorded as yes or no
Child Behavior Checklist (CBCL; 






Internalizing and externalizing domains
consisting of emotionally reactive, 
anxious/
depressed, somatic complaints, 
withdrawn,
attention problems, and aggressive 
behavior
Domain t-scores with a score of 65 
or
more representing problem areas
Mullen Scales of Early Learning





Child age at time of developmental 
evaluation
Early learning composite standard score 
and
visual reception, fine motor, expressive
language, and receptive language abilities
Age defined in months
Early learning composite standard 
score
with scores of 84 or less 
representing
below average abilities
Domain t-scores with scores of 39 
or less
representing below average abilities
Social Communication






Social and communication deficits Continuous total score with scores 
of 15
or more representing clinical risk 
and
scores of 11 or more representing
SEED risk
Social Responsiveness Scale







Severity of social deficit
Receptive, expressive, cognitive, and
motivational aspects of social behavior 
and
ASD preoccupations
Total and domain t-scores with a 
scores
of 60 or more representing problems
areas
a
Scores noted are the standard cutoff recommended by publishers unless otherwise noted (i.e., SCQ score of 11 indicated ASD risk whereas SCQ 
score of 15 indicates clinical risk)
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Table 2
Instruments administered during the comprehensive developmental evaluation of children suspected to have 
an ASD in the Study to Explore Early Development
Data collection (reference) Collection mode Analytic variables Scores
Autism Diagnostic Interview-Revised







Autism cutoff scores are 10 for social
deficits, 7–8 for communication deficits
(depending on verbal abilities of the child),
and 3 for behavioral deficits
Autism Diagnostic Observation Scale
(ADOS; Lord et al. 1999, 2000; Gotham et al. 








Autism spectrum cutoff scores are dependent
on age and/or language abilities of the child
and range from 7 to 11; calibrated symptom
severity score ranging from 1 to 10 with
higher scores representing more severe
symptoms
Vineland Adaptive Behavior Scales,








Total and domain standard scores with scores
of 85 or less representing deficit
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